About us

McRoberts is an innovative and flexible organization with 25 years of experience, and one of the leaders in ambulatory monitoring of physical activity. We apply our knowledge of human movement and analysis of sensor data to facilitate simple solutions in healthcare, clinical studies and research for evaluating physical functioning. Founder and former CEO of McRoberts is Rob van Lummel. His interest in the combination of movement, technology and ICT resulted in the foundation of McRoberts in 1988. In cooperation with scientific partners, epoch-making work has been realized in the development of ambulatory monitoring of physical activity. His wife, Corinne Meurs, who has been an active physiotherapist, joined the company as VP in 2006. In September 2018, after leading our company successfully for 30 years, Rob and Corinne have decided to withdraw from daily management. A young and dynamic team has taken over and will maintain our tradition of continuous improvement and development.


This is what our customers and partners say about us ...

"McRoberts is a very important partner of the UMCM regarding the MyoMobile study, an intervention study on the effects of physical activity on myocardial and vascular function in patients with heart failure.", says Philipp Wild, Professor of Clinical…

Read full testimonial

Univ.-Prof. Dr. med. Philipp Wild, M.Sc.

McRoberts is an important partner for many of our translational research projects”, says Kim Delbaere, Principal Research Scientist – Falls, Balance and Injury Research Centre – at Neuroscience Research Australia. “Our research focus is on…

Read full testimonial

Kim Delbaere, PhD

Our group has been collecting data from community-dwelling older adults using devices made by McRoberts for more than 5 years”, says Aron Buchman, Professor of Neurological Sciences, Rush Alzheimer's Disease Center in Chicago. “It has been a…

Read full testimonial

Aron Buchman, MD

McRoberts is a very important partner for The Hague University of Applied Sciences”, says Willem Looije, Program Manager (The Netherlands). “Since the beginning in 1992, students of our program Human Kinetic Technology are learning and working…

Read full testimonial

Willem Looije

For several years McRoberts and I are collaborating in neuromuscular and aging research,” says Andrea Maier, Professorial Fellow Medicine and Aged Care, University of Melbourne, Australia & Hoogleraar veroudering, Vrije Universiteit Amsterdam.…

Read full testimonial

Andrea Maier, PhD, MD

As the Scientific Coordinator of Moving Beyond, I would like to express my gratitude to Dr. Rob van Lummel and the McRoberts company, for their obviously extensive engagement in the network,” says Walter Maetzler, Department for Neurodegenerative…

Read full testimonial

Walter Maetzler, PhD, MD

I read your paper in PLOS One, based on measurements made with the DynaPort MoveMonitor. Very nice work and a substantial advance in the field…

Read full testimonial

Richard Casaburi, PhD, MD

Since 2012 we have collected over 1000 weeks of gait and activity of daily living data using McRoberts devices with excellent (99%) compliance,” says Professor Stephen Lord, Senior Principal Research Fellow – Falls, Balance and Injury Research…

Read full testimonial

Stephen Lord, PhD

I began working with McRoberts in 2010, finally finding first rate engineers who also were provoked because objective measures of physical activity were not common in clinical research studies for regulatory approval of new therapies,” says Stephen…

Read full testimonial

Stephen Raymond, PhD

We love to work with McRoberts for their outstanding products and services in the area of assessment of physical functioning both in health as in patients with pulmonary diseases,” says Dr. Alex van ‘t Hul, Managing Director COPDnet, Radboudumc…

Read full testimonial

Alex van ‘t Hul, PhD

In the field of activity assessment, McRoberts was known to us from the IMI PROactive project as having a genuine scientific interest in activity assessment and openness to get involved in development of new measures and principles,” says Alan…

Read full testimonial

Alan Hamilton, PhD

2019-2024 IMI Mobilise-D

The title of the five-year project is ‘Linking digital assessment of mobility to clinical endpoints to drive regulatory acceptance and clinical practice’.

Read more All projects


Martijn Niessen, PhD Chief Executive Officer
Jordi Evers, MSc Chief Marketing Officer
Erik Ainsworth, MSc Senior Software Engineer
Sietze de Haan, MSc Software Engineer
Neall Mouthaan, BSc Project Manager
Ali Tabasi, MSc Software Engineer
Rens van Leeuwen, MSc Allround Support Engineer


You can find us at the following events. Feel free to visit our booth (indicated with the icon).



The Digital Biomarker Summit USA
10 May, 2023
Regeneron, Tarrytown, NY, USA

The Digital Biomarker Summit USA will convene industry thought leaders who will share work currently underway with DHTs and digital biomarkers with the goal to propel the industry forward through education and collaboration.

The one-day, invite-only event on May 10, 2023 will showcase examples across a variety of domains, including motor function/mobility, cognitive function, sensory function, and physiological measurement. Additionally, the Summit will demonstrate how design thinking methodologies play a key role in developing digital biomarkers and discuss regulatory guidance and frameworks to help the development and implementation of novel digital endpoints within clinical trials.

Read more
Mobilise-D General Assembly
26 Apr, 2023
Katholieke Universiteit Leuven

Yearly gathering of Mobilise-D Consortium to discuss progress an plan for upcoming year.

Read more
IDEA-FAST General Assembly
16 Mar, 2023
Barcelona, Spain

Yearly gathering of IDEA-FAST Consortium to discuss progress and plan for next year.

Read more
02 Dec, 2022
Berlin, Germany

This congress wants to provide a scientific platform for the exchange on current and future core topics of digitalisation in orthopaedics and traumatology. Digitalisation is significantly changing the way how we provide care for our patients, communicate with colleagues or other healthcare partners, and conduct research.

The concepts of Mobilise-D and MOVITA will be presented during the session mHealth: Apps and Wearables.

Read more
29th Alzheimer Europe Conference
23 Oct, 2019
The Hague

This year the Alzheimer Europe Conference will be held in our hometown The Hague! Together with our partners from the AAL Programme PLAYTIME we will be present our integrated theratainment solution for care, rehab and diagnostics for people suffering from dementia.

Read more


The MoveMonitor and MoveTest are widely used in fundamental and clinical research. Three recent studies are presented below. Browse our full list of peer-reviewed publications here.

Do Functional Tests Estimate Physical Activity in COPD?

Natielly Soares Correia, Joice Mara de Oliveira, Lorena Paltanin Schneider, Andrea Akemi Morita, Fabio Pitta & Karina Couto Furlanetto
May 2023

The aim of this study was to verify the association between functional tests and Physical Activity in Daily Life (PADL) in subjects with COPD, as well as to identify whether these tests can discriminate less active subjects from those who are more physically active.

Read more

Are dietary intake and nutritional status of specifc polyunsaturated fatty acids correlated with sarcopenia outcomes in community-dwelling older adults with sarcopenia? – Exploratory results from ENHANce

Jolan Dupont, Eva Wauters, Lenore Dedeyne, Laura Vercauteren, Nadjia Amini, Laurence Lapauw, Christophe Matthys, Sabine Verschueren, Jos Tournoy, Katrien Koppo and Evelien Gielen
May 2023

The aim of the present study was to assess the dietary intake of polyunsaturated fatty acids (PUFAs) – through food records – and PUFAs status – through e red blood cell membrane fatty acids composition – in a sample of well-defined sarcopenic older adults according to the recent European Working Group on Sarcopenia in Older People (EWGSOP2) criteria. As the first study to do so in this population, we also aimed to determine the correlation between intake and status of PUFAs. Furthermore, the present study intended to explore associations between dietary intake and nutritional status of PUFAs and individual sarcopenia-defining parameters (muscle strength, muscle mass and physical performance) as well as physical activity and quality of life (QoL).

Read more

Instrumented Timed Up and Go Test (iTUG)—More Than Assessing Time to Predict Falls: A Systematic Review

Paulina Ortega-Bastidas, Britam Gómez, Pablo Aqueveque, Soledad Luarte-Martínez and Roberto Cano-de-la-Cuerda
Mar 2023

We present a systematic review that explores the evidence of the technological proposals for the segmentation and analysis of iTUG in elderlies with or without associated pathologies, answering the following questions: What are the technological elements used, the methodological variations, and the main variables extracted in the application of iTUG in elderlies? What are the clinical applicability and predictive value of iTUG in elderlies?

Read more
Show all publications